Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Boyer

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Expert Opinion on Therapeutic Patents|February 11, 2010
RAF modulators and methods of useStephen J Boyer
Current Topics in Medicinal Chemistry|August 13, 2002
Small molecule inhibitors of KDR (VEGFR-2) kinase: an overview of structure activity relationshipsStephen J Boyer
Bioorganic & Medicinal Chemistry Letters|November 8, 2011
Indole RSK inhibitors. Part 2: optimization of cell potency and kinase selectivityThomas M Kirrane, Stephen J Boyer, Jennifer Burke, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2011
Indole RSK inhibitors. Part 1: discovery and initial SARStephen J Boyer, Jennifer Burke, Xin Guo, et al.
Journal of Medicinal Chemistry|July 19, 2012
Identification of a potent sodium hydrogen exchanger isoform 1 (NHE1) inhibitor with a suitable profile for chronic dosing and demonstrated cardioprotective effects in a preclinical model of myocardial infarction in the ratJohn D Huber, Jörg Bentzien, Stephen J Boyer, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 2011
Mitigation of off-target adrenergic binding and effects on cardiovascular function in the discovery of novel ribosomal S6 kinase 2 inhibitorsRyan M Fryer, Akalushi Muthukumarana, Rong Rhonda Chen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Patents|February 11, 2010
RAF modulators and methods of useStephen J Boyer
Current Topics in Medicinal Chemistry|August 13, 2002
Small molecule inhibitors of KDR (VEGFR-2) kinase: an overview of structure activity relationshipsStephen J Boyer
Bioorganic & Medicinal Chemistry Letters|November 8, 2011
Indole RSK inhibitors. Part 2: optimization of cell potency and kinase selectivityThomas M Kirrane, Stephen J Boyer, Jennifer Burke, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2011
Indole RSK inhibitors. Part 1: discovery and initial SARStephen J Boyer, Jennifer Burke, Xin Guo, et al.
Journal of Medicinal Chemistry|July 19, 2012
Identification of a potent sodium hydrogen exchanger isoform 1 (NHE1) inhibitor with a suitable profile for chronic dosing and demonstrated cardioprotective effects in a preclinical model of myocardial infarction in the ratJohn D Huber, Jörg Bentzien, Stephen J Boyer, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 2011
Mitigation of off-target adrenergic binding and effects on cardiovascular function in the discovery of novel ribosomal S6 kinase 2 inhibitorsRyan M Fryer, Akalushi Muthukumarana, Rong Rhonda Chen, et al.
Pageof 1